This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Myriad Genetics to Grow with Study Successes, New Alliances
by Zacks Equity Research
On Jul 6, we issued an updated research report on Myriad Genetics, Inc. (MYGN).
Medtronic (MDT) Launches Resolute Onyx DES Device in Japan
by Zacks Equity Research
Medtronic plc (MDT), a leading global player in medical technology, services and solutions, is set to make another encouraging move with respect to its highest revenue grossing Cardiovascular segment.
Thermo Fisher at a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, MA, scaled a new 52-week high of $177.99 on Jul 7, eventually closing a shade lower at $177.49.
Investors Look for Gains as Abbott Labs Set to Acquire Alere
by Zacks Equity Research
On majority of Alere shareholders' recent approval in favor of the merger with Abbott (ABT), the deal is now expected to close by the end of third-quarter 2017.
Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics
by Zacks Equity Research
Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics
ResMed Sees Potential in SDB Market, Eyes Global Growth
by Zacks Equity Research
On Jul 6, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).
Baxter and TAU Ink New Licensing Agreements through Ramot
by Zacks Equity Research
Baxter International (BAX) has recently teamed up with Tel Aviv University, Israel's largest research and teaching university (TAU), on two new licensing agreements through Ramot.
Mazor Expects Higher Q2 Revenues, Wins Mazor X Orders
by Zacks Equity Research
Mazor Robotics Ltd. (MZOR), recently announced that it expects to report second-quarter 2017 revenue of approximately $15.4 million compared with $8.3 million from the year-ago quarter.
Phibro Animal Health & Zydus Cadila Plan to Expand in India
by Zacks Equity Research
Phibro Animal Health Corporation (PAHC) recently announced plans to enter into a long-term agreement with global pharmaceutical company Zydus Cadila to expand in the rapidly growing poultry market in India.
Edwards Lifesciences' INSPIRIS RESILIA Valve Wins FDA Nod
by Zacks Equity Research
Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for its INSPIRIS RESILIA aortic valve.
Will Walgreens Gain from Revised Rite Aid Agreement?
by Zacks Equity Research
The new agreement would enable Walgreens Boots Alliance (WBA) to buy nearly half of the Rite Aid business at a deal value, almost one-third of the original price.
Exactech Boosts Knee System Portfolio, Launches New App
by Zacks Equity Research
Exactech, Inc.(EXAC) took a step towards it's goal of providing an all-inclusive range of knee replacement systems with the launch of ExactechGPS TKA PLUS.
Here's Why You Should Add Abbott Laboratories Right Now
by Zacks Equity Research
Illinois-based global medical device company Abbott Laboratories (ABT) has been gaining investor confidence on consistent positive results
Envision Healthcare Rallies on Infinity Healthcare Buyout
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) recently announced that Envision Physician Services has acquired Infinity Healthcare, a multi-specialty physician group practice.
Nevro (NVRO) Surges: Stock Moves 11.4% Higher
by Zacks Equity Research
Nevro (NVRO) was a big mover last session, as the company saw its shares rise over 11% on the day.
Exactech (EXAC) Launches Application for Knee Replacement
by Zacks Equity Research
Gainesville, FL-based Exactech Inc. (EXAC) recently announced the launch of a new software application christened ExactechGPS TKA PLUS.
Civitas Solutions (CIVI) Acquires Country Life Care Center
by Zacks Equity Research
Civitas Solutions, Inc. (CIVI) recently announced the acquisition of Country Life Care Center, a rehabilitation and post-acute care facility located in Riverton, UT.
Patterson Companies Grapples with Multiple Issues: Dump Now?
by Zacks Equity Research
On Jul 4, we issued an updated research report on St. Paul, MN-based The Patterson Companies (PDCO).
Omnicell (OMCL) Rides on Acquisitions Amid Tough Competition
by Zacks Equity Research
On Jul 4, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).
Abbott Freestyle Libre System Gets Health Canada License
by Zacks Equity Research
Abbott Laboratories (ABT) recently announced the receipt of Health Canada license for its FreeStyle Libre Flash Glucose Monitoring System.
Veeva (VEEV) Set to Grow on Subscription Revenue Focus
by Zacks Equity Research
On Jul 4, we issued an updated research report on Pleasanton, CA-based Veeva Systems Inc. (VEEV).
PerkinElmer (PKI) Hits a 52-Week High on Multiple Positives
by Zacks Equity Research
PerkinElmer Inc. (PKI) rallied to a new 52-week high of $69.19 on Jul 3, closing lower at $67.73.
Here's Why You Should Dump Quality Systems (QSII) Stock Now
by Zacks Equity Research
On Jul 4, we issued an updated research report on Irvine, CA-based Quality Systems Inc (QSII) -- a developer and marketer of healthcare information systems.
Here's Why You Can Buy Quest Diagnostics Stock Right Now
by Zacks Equity Research
Quest Diagnostics Incorporated (DGX) is on a healthy growth trajectory of late.
Varian Halcyon System Gets 510(k) Approval from the FDA
by Zacks Equity Research
Palo Alto, CA-based manufacturer of medical devices and software, Varian Medical Systems, Inc. (VAR) recently announced the 510(k) approval for its Halcyon system.